Dr. Amitha L. Ananth, M.D.
Child Neurology (Neurology with Special Qualifications in Child Neurology Physician)
At a glance
- Medical school
- University of Alabama School of Medicine (2009)
- Years since graduation
- 17
- In the NPI registry since
- 2011
Licensed in Alabama since 2017, according to the Alabama Board of Medical Examiners and Medical Licensure Commission. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2009Medical school: University of Alabama School of Medicine
- 2011Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology with Special Qualifications in Child Neurology Physician primary
AL license MD36258 (first issued 2017; active) · OR license MD179528 -
Pediatrics Physician
CA license A114447 · OR license MD179528
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- The Children's Hospital of Alabama Birmingham, AL
Medical groups
- University of Alabama Health Services Foundation, PC (2,814 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Carbamazepine Er (carbamazepine) Other prescribers in Birmingham, AL | 12 |
| Clorazepate Dipotassium Other prescribers in Birmingham, AL | 12 |
| Lamotrigine Other prescribers in Birmingham, AL | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 2 payments worth $60.17 in total to this clinician.
| Astellas Pharma US Inc | $37.22 |
|---|---|
| Optinose US, Inc. | $22.95 |
| Food and Beverage | $60.17 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.